2022
DOI: 10.3390/ijms23052496
|View full text |Cite
|
Sign up to set email alerts
|

Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies

Abstract: Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance and recurrent disease are the main obstacles for successful therapy. One of the main reasons for this is the presence of a specific cell population of cancer stem cells. The aim of this review is to show the most contemporary knowledge concerning the biology of ovarian cancer stem cells (OCSCs) and their impact on chemo-resistance and progno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(29 citation statements)
references
References 470 publications
(510 reference statements)
0
29
0
Order By: Relevance
“…Tumoral heterogeneity has been supported by the presence and the maintenance of cancer cells with stemness ability. The CSC model proposed in many studies suggests that this specific subpopulation of cells within the tumor is responsible for disease progression and relapse after standard treatments [ 22 ]. The tumor progression requires different abilities by the subclones, which are present in cells that share stemness profile in Oral and HNSCC, giving a particular marker signature diversity that could result from its functional and molecular plasticity [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Tumoral heterogeneity has been supported by the presence and the maintenance of cancer cells with stemness ability. The CSC model proposed in many studies suggests that this specific subpopulation of cells within the tumor is responsible for disease progression and relapse after standard treatments [ 22 ]. The tumor progression requires different abilities by the subclones, which are present in cells that share stemness profile in Oral and HNSCC, giving a particular marker signature diversity that could result from its functional and molecular plasticity [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…CSCs maintain a cross-talk with immune cells in the TME to promote an immunosuppressive milieu that allows tumor development as a result of escape from the host's immune surveillance [ 22 ]. However, the mechanisms displayed by CSCs that enable their survival under immune vigilance during HNSCC tumorigenesis and metastasis are not well-established [ 23 ].…”
Section: Hncscs and Escape From The Host Immune Surveillancementioning
confidence: 99%
“…By using different phenotype effects, they also take some cells from ovary to study the level of cancer cells present. They want to check out that either they are primarily present there as genetic base or got injected from out through any virus or linked with any other cells [13]. Some promoters are used to stimulate the phenotype effects.…”
Section: Discussionmentioning
confidence: 99%
“…MSCs exert tumor-promoting activity. 50 Moreover, CD90 + CSC-like liver cells-derived CDEs contain lncRNA H19 which enhances the expression of VEGF. 51,52 Similarly CDEs-isolated from OCSCs also facilitated bone marrow MSC migration and enhanced their secretion of VEGF-A, IL-6, and IL-8.…”
Section: Wilczyński Et Al Revealed the Crosstalk Between Cdesderived ...mentioning
confidence: 99%
“…These genes include genes that are related to the promotion of tumor growth, angiogenesis, and cellular migration. Wilczyński et al revealed the crosstalk between CDEs‐derived from ovarian cancer stem cells (OCSCs) and MSCs exert tumor‐promoting activity 50 . Moreover, CD90 + CSC‐like liver cells‐derived CDEs contain lncRNA H19 which enhances the expression of VEGF 51,52 .…”
Section: Role Of Exosome In Csc Communicationmentioning
confidence: 99%